Last updated on November 2017

A Study Evaluating the Safety and Efficacy of Remimazolam (CNS 7056) Compared to Placebo and Midazolam in ASA III and IV Patients Undergoing Colonoscopy


Brief description of study

A Study Evaluating the Safety and Efficacy of Remimazolam (CNS 7056) Compared to Placebo and Midazolam in ASA III and IV Patients Undergoing Colonoscopy

Detailed Study Description

This is a sedation during colonoscopy study. The primary objective of this study is to assess the safety of multiple doses (initial dose and additional top-up doses) of remimazolam compared to placebo and midazolam, following administration of a standard dose of fentanyl.

Procedural sedation in adult patients undergoing colonoscopy for diagnostic or therapeutic purposes. Includes the collection of blood and urine samples, ECGs, and questionnaires, in addition to already scheduled colonoscopy. All participants will receive sedation for the colonoscopy by study drug or by FDA approved medication.

A total of 3 clinic/research visits and one telephone follow up call to each participant.

Clinical Study Identifier: TX7771

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Jeanine Secor

Jupiter Medical Center
Jupiter, FL USA
  Connect »